KMD-3213, a novel α1A-adrenoceptor antagonist, potently inhibits the functional α1-adrenoceptor in human prostate
- 16 July 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 331 (1) , 39-42
- https://doi.org/10.1016/s0014-2999(97)01009-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Quantification and distribution of α1‐adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non‐hypertrophied tissueBritish Journal of Pharmacology, 1996
- Effect of KMD-3213, an α1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aortaEuropean Journal of Pharmacology, 1996
- Detection of α1-adrenoceptor subtypes in human hypertrophied prostate byin situ hybridizationsubtypes in human hypertrophied prostate byin situ hybridizationJournal of Molecular Histology, 1996
- Identification of α1adrenoceptor subtypes in the rabbit prostateJournal of Autonomic Pharmacology, 1995
- Noradrenaline contractions of human prostate mediated by α1c‐(α1c‐) adrenoceptor subtypeBritish Journal of Pharmacology, 1995
- Pharmacological characterization of α1‐adrenoceptor subtypes in the human prostate: functional and binding studiesBritish Journal of Urology, 1994
- COMPARATIVE STUDY ON α1‐ADRENOCEPTOR ANTAGONIST BINDING IN HUMAN PROSTATE AND AORTAClinical and Experimental Pharmacology and Physiology, 1994
- Identification, Quantification, and Localization of mRNA for Three Distinct Alpha1Adrenergic Receptor Subtypes in Human ProstateJournal of Urology, 1993
- Use of an α1-Blocker, YM617, in the Treatment of Benign Prostatic HypertrophyJournal of Urology, 1990